| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cytochrome P450 2A6 |
|---|
| Ligand | BDBM12370 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition Assay |
|---|
| pH | 7.5±n/a |
|---|
| IC50 | 600±n/a nM |
|---|
| Comments | extracted |
|---|
| Citation |  Cashman, JR Synthetic compounds and methods to decrease nicotine self-administration US Patent US8906943 Publication Date 12/9/2014 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cytochrome P450 2A6 |
|---|
| Name: | Cytochrome P450 2A6 |
|---|
| Synonyms: | 1,4-cineole 2-exo-monooxygenase | 1.14.13.- | CP2A6_HUMAN | CYP2A3 | CYP2A6 | CYPIIA6 | Coumarin 7-hydroxylase | Cytochrome P450 2A6 | Cytochrome P450 IIA3 | Cytochrome P450(I) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 56514.34 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P11509 |
|---|
| Residue: | 494 |
|---|
| Sequence: | MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMK
ISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSN
GERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSN
VISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQL
LQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFI
GGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQ
RFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEK
GQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGF
ATIPRNYTMSFLPR
|
|
|
|---|
| BDBM12370 |
|---|
| n/a |
|---|
| Name | BDBM12370 |
|---|
| Synonyms: | (3-(Pyridin-3-yl)-1H-pyrazol-5-yl)methanamine | [3-(3-pyridyl)-1H-pyrazol-5-yl]methylamine;hydrochloride | [3-(pyridin-3-yl)-1H-pyrazol-5-yl]methanamine | nicotine 3-heteroaromatic analogue 32 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C9H10N4 |
|---|
| Mol. Mass. | 174.2025 |
|---|
| SMILES | NCc1cc(n[nH]1)-c1cccnc1 |
|---|
| Structure | 
|
|---|
Search and Browse
